Mehrotra R, Yadav K (2022) Breast cancer in India: present scenario and the challenges ahead. World J Clin Oncol 13(3):209–218. https://doi.org/10.5306/wjco.v13.i3.209

Article  PubMed  PubMed Central  Google Scholar 

India State-Level Disease Burden Initiative Cancer Collaborators (2018) The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol 19(10):1289–1306. https://doi.org/10.1016/S1470-2045(18)30447-9

Article  Google Scholar 

Tomlinson-Hansen S, Khan M, Cassaro S (2023) Breast ductal carcinoma in situ. [Updated 2023 Feb 27]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island. https://www.ncbi.nlm.nih.gov/books/NBK567766/. Accessed 25 Apr 2023

Firdous S, Anjaneyulu FD, Murthy S, Challa S et al (2018) The study of Ductal Carcinoma In Situ (DCIS) with microinvasion using myoepithelial markers. Int J Pathol Clin Res 4:074. https://doi.org/10.23937/2469-5807/1510074

Article  Google Scholar 

Makki J (2015) Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol 21(8):23–31. https://doi.org/10.4137/CPath.S31563

Article  Google Scholar 

Pinder SE, Collins LC, Fox SB, Schnitt SJ, Van Deurzen CHM, Weaver DL, Wesseling J Ductal carcinoma in situ. WHO classification of breast tumors 5th edition. Edited by the WHO Classification of Tumours Editorial Board. Publisher: International Agency for Research on Cancer (IARC), Lyon, pp 76–81

Rakha EA, Allison KH, Ellis IO, Horii R, Masuda S, Penault-Llorca F et al (n.d.) Invasive breast carcinoma: general overview. In: the WHO Classification of Tumours Editorial Board (ed) WHO classification of breast tumors, 5th edn. International Agency for Research on Cancer (IARC), Lylon, pp 82–101

Chen H, Bai F, Wang M, Zhang M, Zhang P, Wu K (2019) The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis. Ann Transl Med 7(18):484. https://doi.org/10.21037/atm.2019.08.16

Article  PubMed  PubMed Central  Google Scholar 

Chagpar AB, McMasters KM, Sahoo S, Edwards MJ (2009) Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis? Surgery 146(4):561–7. https://doi.org/10.1016/j.surg.2009.06.039. (discussion 567-8)

Article  PubMed  Google Scholar 

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM (2008) Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10(5):R87. https://doi.org/10.1186/bcr2157

Article  PubMed  PubMed Central  Google Scholar 

Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ (2006) Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res 8(5):R61. https://doi.org/10.1186/bcr1613

Article  PubMed  PubMed Central  Google Scholar 

Wong H, Lau S, Yau T, Cheung P, Epstein RJ (2010) Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer. Br J Cancer 102(9):1391–1396. https://doi.org/10.1038/sj.bjc.6605655

Article  PubMed  PubMed Central  Google Scholar 

SebastiánSebastián C, García Mur C, Cruz Ciria S, Rosero Cuesta DS, Gros Bañeres B (2016) Imaging and histologic prognostic factors in triple-negative breast cancer and carcinoma in situ as a prognostic factor. Radiologia 58(4):283–93. https://doi.org/10.1016/j.rx.2016.02.004. (English, Spanish)

Article  Google Scholar 

Goh CW, Wu J, Ding S, Lin C, Chen X, Huang O, Chen W, Li Y, Shen K, Zhu L (2019) Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes. J Cancer Res Clin Oncol 145(7):1877–1886. https://doi.org/10.1007/s00432-019-02930-2

Article  PubMed  Google Scholar 

Bertero L, Massa F, Metovic J, Zanetti R, Castellano I, Ricardi U et al (2018) Eighth edition of the UICC classification of malignant tumours: an overview of the changes in the pathological TNM classification criteria-what has changed and why? Virchows Arch 472(4):519–531

Article  PubMed  Google Scholar 

Logullo AF, Godoy AB, Mourão-Neto M, Simpson AJ, Nishimoto IN, Brentani MM (2002) Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma. Braz J Med Biol Res 35(8):913–919. https://doi.org/10.1590/s0100-879x2002000800008

Article  PubMed  Google Scholar 

Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA (2005) Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. J Surg Oncol 90(2):71–76. https://doi.org/10.1002/jso.20242

Article  PubMed  Google Scholar 

Gordo SL, Falp JB, Lopez-Gordo E, Roig EJ, Mendez JE, Calvo JC (2019) Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study. Int J Surg 63:98–106. https://doi.org/10.1016/j.ijsu.2019.01.016

Article  Google Scholar 

Carabias-Meseguer P, Zapardiel I, Cusidó-Gimferrer M, Godoy-Tundidor S, Tresserra-Casas F, Rodriguez-García I, Fábregas-Xauradó R, Xercavins-Montosa J (2013) Influence of the in situ component in 389 infiltrating ductal breast carcinomas. Breast Cancer 20(3):213–217. https://doi.org/10.1007/s12282-011-0330-1

Article  PubMed  Google Scholar 

Lee WP, Shetty SS, Seah CMJ, Tan PT, Tan SM (2022) Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: an Asian perspective. Cancer Rep (Hoboken) 5(9):e1646. https://doi.org/10.1002/cnr2.1646

Article  PubMed  Google Scholar 

Leong AS, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C (2001) Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol 115(5):709–18. https://doi.org/10.1309/wbu9-22qn-c3na-2q12

Article  PubMed  Google Scholar 

Gupta SK, Douglas-Jones AG, Fenn N, Morgan JM, Mansel RE (1997) The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 80(9):1740–1745

Article  PubMed  Google Scholar 

Kim JY, Han W, Moon HG, Park IA, Ahn SK, Kim J, Lee JW, Kim T, Kim MK, Noh DY (2013) Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor. Clin Breast Cancer 13(5):385–391. https://doi.org/10.1016/j.clbc.2013.04.005

Article  PubMed  Google Scholar 

Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12(1):21–29. https://doi.org/10.1016/S1470-2045(10)70266-7

Article  PubMed  Google Scholar 

Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER et al (1999) Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet 353(9169):1993–2000. https://doi.org/10.1016/S0140-6736(99)05036-9

Article  PubMed  Google Scholar 

Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID et al (2012) Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 30(12):1268–1273. https://doi.org/10.1200/JCO.2010.34.0141

Article  PubMed  PubMed Central  Google Scholar